MedBioSphere
Articles Videos The Web  
    

BioSante Pharmaceuticals Presents

Selected Abstract

BioSante Pharmaceuticals Presents Bio-E-Gel(R) Data at North American Menopause Society Meeting.
Bio-E-Gel effective at dose 50 lower than lowest dose of estradiol available to treat hot flashes LINCOLNSHIRE, Ill. -- BioSante Pharmaceuticals, Inc. (Amex: BPA) announced today that it will present safety and efficacy data for Bio-E-Gel([R]) (transdermal estradiol gel), an innovative low-dose ...
October 11, 2006; Business Wire

Read the full article with a free-trial membership at HighBeam Research



Related Articles

1. BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting.
2. BioSante Pharmaceuticals Presents New Anthrax Vaccine Data at World Vaccine Congress.
3. BioSante Pharmaceuticals Presents Positive Results of Oral Insulin Study At IIR-USA Meeting.
4. BioSante Pharmaceuticals Presents CaP Nanotechnology Review at International Conference on Immunopotentiators in Modern Vaccines.
5. BioSante Pharmaceuticals Presents New Significant Bio-E-Gel Phase II Efficacy Results at ASRM Meeting.
6. sents Study Results For Transmucosal Insulin Administration.
7. BioSante Pharmaceuticals Presents Flu Vaccine Data at Novel Vaccines Conference.(Conference news)
8. BioSante Pharmaceuticals Presents Positive Interim Results Using LibiGel for Treatment of Female Sexual Dysfunction.
9. BioSante Pharmaceuticals Presents Bio-E-Gel(R) Data at North American Menopause Society Meeting.
10. BioSante Pharmaceuticals Presents CaP-adjuvanted Bird Flu Vaccine Data at Vaccine Discovery and Commercialization Conference.